Breast Cancer Clinical Trial

Feasibility of Implementing Acupuncture Into Federally Qualified Health Center Among Breast Cancer Survivors

Summary

The purpose of this study is to test the feasibility of implementing acupuncture intervention in federally qualified health centers oncology clinics for breast cancer survivors.

View Full Description

Full Description

This study has the following specific aims:

Aim 1: Test the feasibility and acceptability of implementing a 5-week acupuncture intervention within federally qualified health center oncology clinic to manage multiple symptoms (pain, hot flashes, fatigue, sleep disturbance, depression, anxiety) among breast cancer survivors receiving endocrine therapy.

Aim 2: Use a mixed methods approach to identify barriers and facilitators associated with implementing acupuncture in federally qualified health center oncology clinic.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

women with histologically confirmed stage 0, I, II, or III breast cancer
> 18 years of old
who have completed their primary cancer treatment (e.g., surgery, radiotherapy, chemotherapy) in the past 1 month and currently taking endocrine therapy
are able to read and speak English
with self-reported pain, fatigue, sleep disturbance, depression, hot flashes and/or anxiety in the last month and their average severity rating ≥ 3 (0-10 numeric rating scale) for at least 3 of the 6 symptoms, and experience at least 2 physical symptoms (pain, fatigue, sleep disturbance).

Exclusion Criteria:

Metastatic breast cancer (stage IV)
have a bleeding disorder (e.g. hemophilia, Von Willebrand's disease, thrombocytopenia)
failure to comply with weekly visits to the acupuncture clinic during the interventional phase of the study
Psychiatric or medical disorders which would affect study assessments, such as, dementia, Alzheimer's disease, a history of any neurological condition, traumatic brain injury, stroke, and the use of psychotropic medication
Breastfeeding, pregnant or are planning get pregnant during the study period

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

62

Study ID:

NCT05615753

Recruitment Status:

Recruiting

Sponsor:

University of Illinois at Chicago

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Illinois at Chicago
Chicago Illinois, 60601, United States More Info
Hongjin Li
Contact
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

62

Study ID:

NCT05615753

Recruitment Status:

Recruiting

Sponsor:


University of Illinois at Chicago

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.